BridgeBio Pharma, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
BridgeBio Pharma, Inc. (BBIO) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $4.67 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-10
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.67M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.80M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $870.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $745.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $4.67M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $4.80M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $870.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $745.00K 10-Q · filed 2025-10-29 |
| 2025-06-30 | $790.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $916.00K 10-Q · filed 2025-04-29 |
| 2024-12-31 | $900.00K 10-K · filed 2025-02-20 |
| 2024-09-30 | $1.14M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.30M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $1.50M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.77M 10-K · filed 2024-02-22 |
| 2023-09-30 | $1.95M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.17M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $2.38M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.53M 10-K · filed 2023-02-23 |
| 2022-09-30 | $2.75M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.08M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.39M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $3.73M 10-K · filed 2022-02-25 |
| 2021-09-30 | $4.04M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.28M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.09M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $3.35M 10-K · filed 2021-02-25 |
| 2020-09-30 | $2.02M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.20M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $2.29M 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |